Ad is loading...
ICMBX
Price
$12.61
Change
-$0.04 (-0.32%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

ICMBX vs RLEFX

Header iconICMBX vs RLEFX Comparison
Open Charts ICMBX vs RLEFXBanner chart's image
Intrepid Capital Investor
Price$12.61
Change-$0.04 (-0.32%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
ICMBX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ICMBX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICMBX is a Buy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. ICMBX (48.8M). ICMBX pays higher dividends than RLEFX: ICMBX (3.87) vs RLEFX (2.42). ICMBX was incepted earlier than RLEFX: ICMBX (20 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. ICMBX (57.00). RLEFX has a lower initial minimum investment than ICMBX: RLEFX (250) vs ICMBX (2500). RLEFX (21.09) and ICMBX (20.56) have marching annual gain over last year. ICMBX return over 5 years is better than : 41.68 vs. RLEFX (35.95).
ICMBXRLEFXICMBX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years9 years-
Gain YTD14.85314.211105%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets48.8M236B0%
Annual Yield % from dividends3.872.42160%
Returns for 1 year20.5621.0997%
Returns for 3 years13.1910.95120%
Returns for 5 years41.6835.95116%
Returns for 10 years26.74N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology